Brian Lian
Board Member
Viking Therapeutics, Inc. (VKTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $672,000 | $21,269,833 |
| 2024 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $640,000 | $14,298,554 |
| 2023 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $615,000 | $12,628,061 |
| 2022 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $611,800 | $5,411,291 |
| 2021 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $594,000 | $4,059,119 |
| 2020 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $577,000 | $5,187,448 |
| 2019 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $525,000 | $3,512,119 |
| 2018 | Viking Therapeutics, Inc. (VKTX) | Chief Executive Officer | $485,000 | $1,403,283 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.